Skip to main content

Closed

ATRA: Atara Biotherapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-27.3%

ROIC-41.1%

Financially safe

Stretched

Debt / equity-0.27×

Interest coverage-1.8×

Current ratio2.16×

Atara Biotherapeutics, Inc.

ATRANASDAQ Global Select·USD·Closed

Atara Biotherapeutics, Inc.

ATRANASDAQ·USD·Closed

$8.38

+2.57%

$8.38

+$0.21 (2.57%)

52W Range

29thpctl

Volume

0.02×avg

Mkt Cap

75.51MUSD

P/E

-12.7TTM

Div Yield

–ann

52W Range

29thpctl

Volume

0.02×avg

Market Cap

75.51MUSD

P/E Ratio

-12.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings